MedPath

Korea Institute of Oriental Medicine

🇰🇷South Korea
Ownership
Private
Established
1994-01-01
Employees
-
Market Cap
-
Website
https://kiom.re.kr/

Clinical Trials

137

Active:6
Completed:57

Trial Phases

4 Phases

Phase 1:1
Phase 2:1
Phase 3:3
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (135 trials with phase data)• Click on a phase to view related trials

Not Applicable
130 (96.3%)
Phase 3
3 (2.2%)
Phase 1
1 (0.7%)
Phase 2
1 (0.7%)

Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer

Phase 2
Recruiting
Conditions
Non-small Cell Lung Cancer
Interventions
Drug: Bojungikki-tang(BJIKT)
First Posted Date
2024-02-08
Last Posted Date
2024-10-01
Lead Sponsor
Korea Institute of Oriental Medicine
Target Recruit Count
70
Registration Number
NCT06249854
Locations
🇰🇷

The catholic university of Korea Seoul Saint. Mary's hospital, Seoul, Korea, Republic of

🇰🇷

Hallym University Medical Center, Anyang-si, Gyeonggi-do, Korea, Republic of

🇰🇷

Pusan National University Yangsan Hospital, Yangsan, Gyeongsangnam-do, Korea, Republic of

and more 4 locations

A Multicenter Observational Study on Safety of the Herbal Medicines at Inpatient Setting

Active, not recruiting
Conditions
Drug Induced Liver Injury
Drug-Induced Kidney Injury
Herbal Medicine Adverse Reaction
First Posted Date
2020-02-13
Last Posted Date
2023-03-09
Lead Sponsor
Korea Institute of Oriental Medicine
Target Recruit Count
287
Registration Number
NCT04269486
Locations
🇰🇷

Five tertiary Korean Medicine Hospital (Jecheon, Yangsan, Gwangju, Seoul, Bundang), Seoul, Korea, Republic of

A Study of Characterizing Cognitive Decline and Functional Cardiac Senescence in Healthy Korean Volunteers

Completed
Conditions
Mild Cognitive Impairment
Angina Pectoris
Aging
First Posted Date
2012-05-03
Last Posted Date
2014-04-02
Lead Sponsor
Korea Institute of Oriental Medicine
Target Recruit Count
116
Registration Number
NCT01590706
Locations
🇰🇷

Dunsan Oriental Hospital of Daejeon Univ., Daejeon, Korea, Republic of

Moxibustion for Knee Osteoarthritis

Phase 1
Completed
Conditions
Idiopathic Osteoarthritis
First Posted Date
2011-05-17
Last Posted Date
2011-05-17
Lead Sponsor
Korea Institute of Oriental Medicine
Target Recruit Count
40
Registration Number
NCT01354860
Locations
🇰🇷

Daejeon University Hospital, Daejeon, Korea, Republic of

Acupuncture for Dry Eye

Phase 3
Completed
Conditions
Dry Eye
Interventions
Device: Acupuncture
Drug: Refresh Plus
First Posted Date
2010-04-16
Last Posted Date
2011-01-10
Lead Sponsor
Korea Institute of Oriental Medicine
Target Recruit Count
150
Registration Number
NCT01105221
Locations
🇰🇷

Clinical Research Center of DongGuk Univ. Internaltional Hospital, Goyang, Gyeonggi, Korea, Republic of

🇰🇷

Clinical Research Center of Korea Institute of Oriental Medicine, Daejeon, Korea, Republic of

🇰🇷

Clinical Research Center of DongShin Univ. Oriental Hospital, Gwangju, Korea, Republic of

  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.